User:Syed Hassan Abbas Kazmi: Difference between revisions

Jump to navigation Jump to search
Line 36: Line 36:
* [[Dermatophytosis]]
* [[Dermatophytosis]]
* [[Whipworm infection]]
* [[Whipworm infection]]
{{ColBreak}}
* [[Bourbon virus infection]]
* [[Bourbon virus infection]]
* [[Sleep deprivation survey]]
* [[Sleep deprivation survey]]
Line 44: Line 45:
* [[Nephrolithiasis]]
* [[Nephrolithiasis]]
* [[Hematuria]]
* [[Hematuria]]
{{ColBreak}}
* [[Venous thromboembolism|Venous Thromboembolism]]
* [[Venous thromboembolism|Venous Thromboembolism]]
* [[Down syndrome|Down's Syndrome]]
* [[Down syndrome|Down's Syndrome]]
Line 53: Line 55:
* [[Deep vein thrombosis medical therapy]]
* [[Deep vein thrombosis medical therapy]]
* Drug page for Andexxa (Reversal agent for Factor Xa inhibitors- approved by FDA in May 2018)
* Drug page for Andexxa (Reversal agent for Factor Xa inhibitors- approved by FDA in May 2018)
{{ColBreak}}
*  [https://cardiologynownews.org/corevalve-evolut-r-and-edwards-sapien-3-valves-reveal-equivalence-in-transcatheter-aortic-valve-implantation-tavi-in-a-head-to-head-comparison/ Corevalve Evolut R (Medtronic) and Edwards Sapien 3 (Edward Lifesciences) Valves Reveal Equivalence in Transcatheter Aortic Valve Implantation (TAVI) in a Head-to-Head Comparison]
*  [https://cardiologynownews.org/corevalve-evolut-r-and-edwards-sapien-3-valves-reveal-equivalence-in-transcatheter-aortic-valve-implantation-tavi-in-a-head-to-head-comparison/ Corevalve Evolut R (Medtronic) and Edwards Sapien 3 (Edward Lifesciences) Valves Reveal Equivalence in Transcatheter Aortic Valve Implantation (TAVI) in a Head-to-Head Comparison]
* [https://cardiologynownews.org/polymer-coated-sustained-release-eluvia-des-outshines-non-polymer-coated-zilver-des-for-femoropopliteal-artery-stenosis/ Polymer coated sustained-release Eluvia DES outshines non-polymer coated Zilver DES for femoropopliteal artery stenosis]
* [https://cardiologynownews.org/polymer-coated-sustained-release-eluvia-des-outshines-non-polymer-coated-zilver-des-for-femoropopliteal-artery-stenosis/ Polymer coated sustained-release Eluvia DES outshines non-polymer coated Zilver DES for femoropopliteal artery stenosis]

Revision as of 16:29, 24 October 2018

Syed Hassan Abbas Kazmi

Syed Hassan Abbas Kazmi, B.Sc, M.D.
Contact:
Email: skazmi@bidmc.harvard.edu

Current Position

  • Associate Editor-in-Chief, WikiDoc.org
  • Postdoctoral Research Fellow, PERFUSE Study Group

Professional Background

Dr. Hassan Kazmi is currently working as a research fellow at Beth Israel Deaconess Medical Center, Harvard University in Boston, Massachusetts. He received his M.B;B.S. degree from the King Edward Medical University in Lahore, Pakistan, after which he was involved in research projects with Government College University, Lahore and at San Jose State University, San Jose. He then joined as a post-doctoral research fellow at PERFUSE Study Group. Dr. Kazmi is an associate editor-in-chief at WikiDoc.org, where he authors and peer-reviews content in Oncology, Cardiovascular medicine, Nephrology, Infectious disease, Gastroenterology, Hematology, Neurology, Pulmonary medicine and Endocrinology.

Education

  • 2016 - M.D. and ECFMG Certification
  • 2013 - M.B;B.S. Degree, King Edward Medical University, Lahore, Pakistan
  • 2011 - Bachelor of Sciences Degree, University of Punjab, Lahore, Pakistan

Clinical Experience

  • 2010-2012 - Clinical rotations , Mayo Hospital Lahore, Pakistan
  • 2012 - Clinical rotations, Internal medicine and critical care departments, The Hospital of Central Connecticut, University of Connecticut (Uconn), USA
  • 2013-2014 - Intern General Hospital Lahore, Pakistan
  • 2014-2016 - Medical officer, Internal medicine department, Mayo Hospital Lahore, Pakistan
  • 2016 - Extern Starling Physicians Group
  • 2016 - Extern, Internal medicine department, Wilkes Regional Medical Center, Wilkesboro, North Carolina, USA
  • 2017 - Extern, Cardiology, Heart and Vascular Institute (DMC), Dearborn/Southfield, Michigan, USA

Authored Pages